Mortality prediction at the tracheostomy decision point after liver transplantation: development and internal validation of a bedside risk score

BACKGROUND: Liver-transplant (LT) recipients requiring prolonged ventilation and considered for percutaneous dilatational tracheostomy (PDT) have high short-term mortality, but LT-specific tools to support prognosis-aligned communication at this decision point are lacking. We developed and internally validated a simple PDT-day model and an integer Tracheostomy Decision-Point Risk Score (TRS) to estimate 90-day mortality from the PDT decision point in LT recipients undergoing PDT. METHODS: This retrospective single-center cohort included 83 adult LT recipients undergoing PDT between December 2010 and June 2024. The primary outcome was all-cause mortality within 90 days from the PDT decision point, operationalized as the day of PDT. The model estimates risk after the PDT decision point and not the causal effect of PDT. Logistic regression used routinely available PDT-day variables; internal validation used bootstrap shrinkage. Discrimination and calibration were assessed by AUC, Brier score, calibration-in-the-large, and calibration slope. Coefficients were converted to an integer TRS. RESULTS: 90-day mortality was 62.7% (52/83). Model for End-Stage Liver Disease (MELD; +5 points), age (+ 10 years), and activated partial thromboplastin time (aPTT; +5 s) measured on the PDT day were independently associated with 90-day mortality (adjusted odds ratios 2.54 [95% confidence interval (CI) 1.45-4.47], 1.97 [1.16-3.36], and 1.53 [1.02-2.28], respectively; all p ≤ 0.040). Discrimination was good (AUC 0.846; bootstrap-corrected AUC 0.829 [95% CI 0.74-0.93]) with favorable calibration (calibration-in-the-large - 0.01; slope 1.02). The TRS (+ 2 points per + 5 MELD, + 2 per + 10 years, + 1 per + 5 s aPTT) retained discrimination (AUC 0.831) and stratified observed 90-day mortality: 38% (14/37) low, 72% (13/18) intermediate, and 89% (25/28) high. 90-day survival differed across bands (global log-rank p < 0.001). CONCLUSIONS: For LT recipients who reach the PDT decision point and undergo PDT, the TRS provides internally validated 90-day mortality estimates that may support prognosis-informed multidisciplinary deliberation and bedside risk communication. It should be used only as one component of decision-making and does not estimate the causal effects of PDT, no-PDT strategies, or PDT timing. Use in prolonged-ICU LT recipients without PDT requires separate validation.

Authors

Institutions

Publication Details

Journal
BMC Anesthesiology
Published
2026-11-18
DOI
https://doi.org/10.1186/s12871-026-04426-2
Primary Topic
Tracheal and airway disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mortality prediction at the tracheostomy decision point after liver transplantation: development and internal validation of a bedside risk score

Eugen Malamutmann, Jassin Rashidi‐Alavijeh, Dieter Paul Hoyer, Arzu Oezcelik et al.
BMC Anesthesiology
Tracheal and airway disorders
article

Mortality prediction at the tracheostomy decision point after liver transplantation: development and internal validation of a bedside risk score

Eugen Malamutmann, Jassin Rashidi‐Alavijeh, Dieter Paul Hoyer, Arzu Oezcelik, Katharina Willuweit, Ulf P. Neumann, Miroslav Jalč
article en

Abstract

BACKGROUND: Liver-transplant (LT) recipients requiring prolonged ventilation and considered for percutaneous dilatational tracheostomy (PDT) have high short-term mortality, but LT-specific tools to support prognosis-aligned communication at this decision point are lacking. We developed and internally validated a simple PDT-day model and an integer Tracheostomy Decision-Point Risk Score (TRS) to estimate 90-day mortality from the PDT decision point in LT recipients undergoing PDT. METHODS: This retrospective single-center cohort included 83 adult LT recipients undergoing PDT between December 2010 and June 2024. The primary outcome was all-cause mortality within 90 days from the PDT decision point, operationalized as the day of PDT. The model estimates risk after the PDT decision point and not the causal effect of PDT. Logistic regression used routinely available PDT-day variables; internal validation used bootstrap shrinkage. Discrimination and calibration were assessed by AUC, Brier score, calibration-in-the-large, and calibration slope. Coefficients were converted to an integer TRS. RESULTS: 90-day mortality was 62.7% (52/83). Model for End-Stage Liver Disease (MELD; +5 points), age (+ 10 years), and activated partial thromboplastin time (aPTT; +5 s) measured on the PDT day were independently associated with 90-day mortality (adjusted odds ratios 2.54 [95% confidence interval (CI) 1.45-4.47], 1.97 [1.16-3.36], and 1.53 [1.02-2.28], respectively; all p ≤ 0.040). Discrimination was good (AUC 0.846; bootstrap-corrected AUC 0.829 [95% CI 0.74-0.93]) with favorable calibration (calibration-in-the-large - 0.01; slope 1.02). The TRS (+ 2 points per + 5 MELD, + 2 per + 10 years, + 1 per + 5 s aPTT) retained discrimination (AUC 0.831) and stratified observed 90-day mortality: 38% (14/37) low, 72% (13/18) intermediate, and 89% (25/28) high. 90-day survival differed across bands (global log-rank p < 0.001). CONCLUSIONS: For LT recipients who reach the PDT decision point and undergo PDT, the TRS provides internally validated 90-day mortality estimates that may support prognosis-informed multidisciplinary deliberation and bedside risk communication. It should be used only as one component of decision-making and does not estimate the causal effects of PDT, no-PDT strategies, or PDT timing. Use in prolonged-ICU LT recipients without PDT requires separate validation.

BMC AnesthesiologyVol. 26(1)
Essen University Hospital (DE)
Universitätsklinikum Essen
Good health and well-being
Tracheal and airway disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon